Cargando…
Positron emission tomography: Evolving modalities, radiopharmaceuticals and professional collaboration
Positron emission tomography (PET) as an imaging modality has undergone considerable innovation over the past few decades. Hybrid anatomical and functional imaging has become commonplace (initially PET/CT but now also PET/MRI) with improvements in imaging technology continually delivering studies wi...
Autores principales: | Ayesa, Sally L., Murphy, Andrew |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9714494/ https://www.ncbi.nlm.nih.gov/pubmed/36334076 http://dx.doi.org/10.1002/jmrs.629 |
Ejemplares similares
-
Positron Emission Tomography Radiopharmaceuticals in Differentiated Thyroid Cancer
por: Sakulpisuti, Chaninart, et al.
Publicado: (2022) -
Chelators for copper radionuclides in positron emission tomography radiopharmaceuticals()
por: Cai, Zhengxin, et al.
Publicado: (2013) -
Current Radiopharmaceuticals for Positron Emission Tomography of Brain Tumors
por: Jung, Ji-hoon, et al.
Publicado: (2018) -
Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma
por: Sachpekidis, Christos, et al.
Publicado: (2019) -
Quality control of positron emission tomography radiopharmaceuticals: An institutional experience
por: Shukla, Jaya, et al.
Publicado: (2013)